Molnupiravir for the treatment of non-severe COVID-19: a systematic review and meta-analysis of 14 randomized trials with 34  570 patients

ConclusionsMolnupiravir was found to be effective in non-severe COVID-19, but the efficacy varied with age and sex.
Source: Journal of Antimicrobial Chemotherapy - Category: Microbiology Source Type: research